MRK
Merck & Co., Inc. · Healthcare
Chair, CEO and President Robert M Davis sold $29.5M of Merck & Co., Inc.
Sold$29,538,998
$125.69Price
235,021Shares
−40%Stake
What MRK did after the filing
- The stock from Fri, Feb 16 open, $126.50
- +3.0%
- S&P 500, same days
- +3.7%
Measured over 30 trading days, to the Apr 2 close.
Traded Tue, Feb 13. Filed Thu, Feb 15, 4:01 PM ET, after the close. Returns use the Feb 16 open and the Apr 2 close. Not investment advice.